Table 1.
Preoperative data in the ultra-short-course chemotherapy group and in the standard chemotherapy group
| The ultra-short-course chemotherapy group | The standard chemotherapy group | 95 % CI | P value | |
|---|---|---|---|---|
| Mean age (x ± s) | 37.96 ± 16.30 | 41.53 ± 15.76 | −8.227 to 1.087 | 0.132 |
| Number of males/females (n = 185) | 54/42 (96) | 50/39 (89) | – | – |
| Lesion location (n = 185) | 96 | 89 | – | – |
| Cervical vertebrae | 4/96 (4.2) | 3/89 (3.4) | – | – |
| Cervical and thoracic vertebrae | 2/96 (2.1) | 1/89 (1.1) | – | – |
| Thoracic vertebrae | 20/96 (20.8) | 18/89 (20.2) | – | – |
| Thoracolumbar segment | 17/96 (17.7) | 25/89 (28.1) | – | – |
| Lumbar vertebrae | 40/96 (41.7) | 32/89 (36.0) | – | – |
| Lumbosacral segment | 13/96 (13.5) | 10/89 (11.2) | – | – |
| Vertebral involvement (n = 185) | 96 | 89 | – | – |
| 1 or 2 vertebrae | 64/96 (66.7) | 66/89 (74.2) | – | – |
| ≥3 vertebrae | 32/96 (33.3) | 23/89 (25.8) | – | – |
| The kyphosis Cobb angle (n = 185) | 20.53 ± 8.64° | 19.35 ± 8.65° | −1.327 to 3.693 | 0.354 |
| Abscess (n = 160) | 83/96 (86.5) | 77/89 (86.5) | – | – |
| Nerve compression (n = 54) | 30/96 (31.3) | 24/89 (27.0) | – | – |
| Combined with other parts TB | 6 | 7 | – | – |
| ESR (mm/H) | 53.18 ± 18.12 | 54.66 ± 18.72 | −6.831 to 3.859 | 0.548 |
| CRP (mg/L) | 27.11 ± 11.93 | 28.15 ± 13.44 | −4.728 to 2.633 | 0.575 |
| Duration of follow-up (months) | 74.15 ± 7.44 | 74.08 ± 7.38 | −2.084 to 2.219 | 0.951 |
The values without a unit are shown as number of cases/number of total cases (%)